Showing results (1731-1740 of 2,048) with videos related to
Sort By:
Pageof 205
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.Journal of Cardiac Failure|June 6, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapyJoseph R Evans, Shuang Zhao, Stephanie Daignault, et al.Heart Failure Reviews|February 5, 2015
Site selection for heart failure clinical trials in the USAMatthew E Harinstein, Javed Butler, Stephen J Greene, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.Journal of Medicinal Chemistry|September 9, 2011
Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agentMaria-Elena Theoclitou, Brian Aquila, Michael H Block, et al.Advances in Radiation Oncology|September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control SeriesJesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.Scientific Reports|July 28, 2025
Molecular characterization of human respiratory syncytial virus in Mexico (season 2023-2024) through whole-genome sequencingEvelyn Rivera-Toledo, Fidencio Mejıa-Nepomuceno, Enrique Mendoza-Ramırez, et al.The Lancet. Haematology|April 29, 2018
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trialMary Gleeson, Clare Peckitt, Ye Mong To, et al.Chest|May 3, 2022
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset HypoxemiaAri Moskowitz, Matthew S Shotwell, Kevin W Gibbs, et al.Pageof 205